| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024432 |
| Receipt No. | R000027703 |
| Official scientific title of the study | A randomised controlled trial of the heat-killed Pediococcus acidilactici K15 in preschool children to prevent viral respiratory tract infection |
| Date of disclosure of the study information | 2016/10/18 |
| Last modified on | 2018/10/22 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | A randomised controlled trial of the heat-killed Pediococcus acidilactici K15 in preschool children to prevent viral respiratory tract infection | |
| Title of the study (Brief title) | The heat-killed Pediococcus K15 in preschool children trial | |
| Region |
|
|
| Condition | ||
| Condition | Prevention of viral respiratory tract infection | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this research is to evaluate the effect of heat-killed Pediococcus K15 in prevention of viral respiratory tract infections for children attending preschool. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | The number of febrile days during the exam period |
| Key secondary outcomes | The number of absent days due to common cold symptoms
The incidence of influenza which were diagnosed by physician The duration of fever during influenza infection Salivary influenza-specific IgA or IgG/total IgA or IgGantibody levels in samples collected before and after treatment Metabolic Profiling of salivary samples by NMR Side effect associated with intake of K15 (abdominal pain, exanthema etc.) The analysis of intestinal bacterial flora in stool samples |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | heat-killed Pediococcus acidilactici K15 (10mg/day, 4months) | |
| Interventions/Control_2 | Dextrin (10mg/day, 4months) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy 3-6 year old children attending kindergarten | |||
| Key exclusion criteria | 1)Patients with a precious allergy to Lactic acid bacteria or soy beans.
2)Patients with congenital heart disease or severe respiratory disease. 3)Patients born as premature birth newborn (fetus age was <37 weeks or body weight was <2,500g). 4)Patients who were determined as unsuitable subjects by investigators. |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Shimojo |
| Organization | Chiba University School of Medicine |
| Division name | Department of Pediatrics |
| Address | 1-8-1 Inohana Chiba, Chuo-ku, Japan |
| TEL | 043-222-7171 |
| shimojo@faculty.chiba-u.jp | |
| Public contact | |
| Name of contact person | Haruka Hishiki |
| Organization | Chiba University Hospital |
| Division name | Department of Pediatrics |
| Address | 1-8-1 Inohana Chiba, Chuo-ku, Japan |
| TEL | 043-222-7171 |
| Homepage URL | |
| hishikih@faculty.chiba-u.jp | |
| Sponsor | |
| Institute | Chiba University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Chiba University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | National institute of advanced industrial science and technology
Institute for Enzyme Research, Tokushima University |
| Name of secondary funder(s) | Kikkoman Corporation |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 千葉大学医学部附属病院(千葉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027703 |